TY - JOUR
T1 - Superiority of Step-up Approach vs Open Necrosectomy in Long-term Follow-up of Patients With Necrotizing Pancreatitis
AU - Hollemans, Robbert A.
AU - Bakker, Olaf J.
AU - Boermeester, Marja A.
AU - Bollen, Thomas L.
AU - Bosscha, Koop
AU - Bruno, Marco J.
AU - Buskens, Erik
AU - Dejong, Cornelis H.
AU - van Duijvendijk, Peter
AU - van Eijck, Casper H.
AU - Fockens, Paul
AU - van Goor, Harry
AU - van Grevenstein, Wilhelmina M.
AU - van der Harst, Erwin
AU - Heisterkamp, Joos
AU - Hesselink, Eric J.
AU - Hofker, Sijbrand
AU - Houdijk, Alexander P.
AU - Karsten, Tom
AU - Kruyt, Philip M.
AU - van Laarhoven, Cornelis J.
AU - Lameris, Johan S.
AU - van Leeuwen, Maarten S.
AU - Manusama, Eric R.
AU - Molenaar, I. Quintus
AU - Nieuwenhuijs, Vincent B.
AU - van Ramshorst, Bert
AU - Roos, Daphne
AU - Rosman, Camiel
AU - Schaapherder, Alexander F.
AU - van der Schelling, George P.
AU - Timmer, Robin
AU - Verdonk, Robert C.
AU - de Wit, Ralph J.
AU - Gooszen, Hein G.
AU - Besselink, Marc G.
AU - van Santvoort, Hjalmar C.
AU - Dutch Pancreatitis Study Grp
N1 - Funding Information:
Funding Funded by the Dutch Digestive Disease Foundation (grant no. CDG12-07). The funder had no role in the study design and the collection, analysis, and interpretation of the data.
Publisher Copyright:
© 2019 AGA Institute
PY - 2019/3
Y1 - 2019/3
N2 - BACKGROUND & AIMS: In a 2010 randomized trial (the PANTER trial), a surgical step-up approach for infected necrotizing pancreatitis was found to reduce the composite endpoint of death or major complications compared with open necrosectomy; 35% of patients were successfully treated with simple catheter drainage only. There is concern, however, that minimally invasive treatment increases the need for reinterventions for residual peripancreatic necrotic collections and other complications during the long term. We therefore performed a long-term follow-up study. METHODS: We reevaluated all the 73 patients (of the 88 patients randomly assigned to groups) who were still alive after the index admission, at a mean 86 months (+/- 11 months) of follow-up. We collected data on all clinical and health care resource utilization endpoints through this follow-up period. The primary endpoint was death or major complications (the same as for the PANTER trial). We also measured exocrine insufficiency, quality of life (using the Short Form-36 and EuroQol 5 dimensions forms), and Izbicki pain scores. RESULTS: From index admission to long-term follow-up, 19 patients (44%) died or had major complications in the step-up group compared with 33 patients (73%) in the open-necrosectomy group (P = .005). Significantly lower proportions of patients in the step-up group had incisional hernias (23% vs 53%; P = .004), pancreatic exocrine insufficiency (29% vs 56%; P = .03), or endocrine insufficiency (40% vs 64%; P = .05). There were no significant differences between groups in proportions of patients requiring additional drainage procedures (11% vs 13%; P = .99) or pancreatic surgery (11% vs 5%; P = .43), or in recurrent acute pancreatitis, chronic pancreatitis, Izbicki pain scores, or medical costs. Quality of life increased during follow-up without a significant difference between groups. CONCLUSIONS: In an analysis of long-term outcomes of trial participants, we found the step-up approach for necrotizing pancreatitis to be superior to open necrosectomy, without increased risk of reinterventions.
AB - BACKGROUND & AIMS: In a 2010 randomized trial (the PANTER trial), a surgical step-up approach for infected necrotizing pancreatitis was found to reduce the composite endpoint of death or major complications compared with open necrosectomy; 35% of patients were successfully treated with simple catheter drainage only. There is concern, however, that minimally invasive treatment increases the need for reinterventions for residual peripancreatic necrotic collections and other complications during the long term. We therefore performed a long-term follow-up study. METHODS: We reevaluated all the 73 patients (of the 88 patients randomly assigned to groups) who were still alive after the index admission, at a mean 86 months (+/- 11 months) of follow-up. We collected data on all clinical and health care resource utilization endpoints through this follow-up period. The primary endpoint was death or major complications (the same as for the PANTER trial). We also measured exocrine insufficiency, quality of life (using the Short Form-36 and EuroQol 5 dimensions forms), and Izbicki pain scores. RESULTS: From index admission to long-term follow-up, 19 patients (44%) died or had major complications in the step-up group compared with 33 patients (73%) in the open-necrosectomy group (P = .005). Significantly lower proportions of patients in the step-up group had incisional hernias (23% vs 53%; P = .004), pancreatic exocrine insufficiency (29% vs 56%; P = .03), or endocrine insufficiency (40% vs 64%; P = .05). There were no significant differences between groups in proportions of patients requiring additional drainage procedures (11% vs 13%; P = .99) or pancreatic surgery (11% vs 5%; P = .43), or in recurrent acute pancreatitis, chronic pancreatitis, Izbicki pain scores, or medical costs. Quality of life increased during follow-up without a significant difference between groups. CONCLUSIONS: In an analysis of long-term outcomes of trial participants, we found the step-up approach for necrotizing pancreatitis to be superior to open necrosectomy, without increased risk of reinterventions.
KW - Pancreas
KW - Infected Necrosis
KW - Minimally Invasive
KW - Pancreatic Surgery
KW - QUALITY-OF-LIFE
KW - SF-36 HEALTH SURVEY
KW - FECAL ELASTASE-1
KW - MANAGEMENT
KW - EQ-5D
KW - CLASSIFICATION
KW - GUIDELINES
KW - NECROSIS
KW - STATES
U2 - 10.1053/j.gastro.2018.10.045
DO - 10.1053/j.gastro.2018.10.045
M3 - Article
C2 - 30391468
SN - 0016-5085
VL - 156
SP - 1016
EP - 1026
JO - Gastroenterology
JF - Gastroenterology
IS - 4
ER -